DrugPatentWatch Database Preview
Amphastar Pharm Company Profile
» See Plans and Pricing
US Patents for Amphastar Pharm
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | RE47849 | HOUGH EAR INSTITUTE (Oklahoma City, OK) | 2022-12-18 | RX | search | |
Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | RE37336 | The Board of Regents of the University of Oklahoma (Norman, OK) | 2040-03-31 | RX | search | |
Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | 9,994,849 | SAMSUNG ELECTRONICS CO., LTD. (Suwon-si, KR) | 2035-12-24 | RX | search | |
Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | 9,993,529 | Halozyme, Inc. (San Diego, CA) | 2028-04-28 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |